News

Deal Announcements

Amorcyte Raises More Venture Capital Financing

Friday, November 26, 2010 5:51:00 AM PDT | VentureDeal Staff
  Allendale, New Jersey  --  Biotechnology company Amorcyte has garnered $525,000 in new venture capital financing according to an SEC regulatory filing.

Amorcyte is developing cell therapy products to treat cardiovascular diseases.

Investors in the financing weren't disclosed, nor was how the company intends to use the proceeds.

Amorcyte is backed by Novitas Capital and other undisclosed investors.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1